![Single-tablet DAA in a patient with chronic hepatitis C and decompensated liver cirrhosis | Latest news for Doctors, Nurses and Pharmacists | Gastroenterology Single-tablet DAA in a patient with chronic hepatitis C and decompensated liver cirrhosis | Latest news for Doctors, Nurses and Pharmacists | Gastroenterology](https://pubmiddleware.mims.com/resource/image/2A366130-86BC-493F-B781-AF2601086EFC/OriginalThumbnail/THUMBNAIL_shutterstock_1994999621.jpg)
Single-tablet DAA in a patient with chronic hepatitis C and decompensated liver cirrhosis | Latest news for Doctors, Nurses and Pharmacists | Gastroenterology
![Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study | Alan Yeung Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study | Alan Yeung](https://alan-y.netlify.app/publication/journal-article-hcv_daa_dc/featured_hua6a028727cfb194fde8de7d3ee5ee7f4_60058_680x500_fill_q90_lanczos_smart1_2.png)
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study | Alan Yeung
![Reimbursement restrictions of DAAs for the treatment of Hepatitis C in Canada | CanHepC - Canadian Network on Hepatitis C Reimbursement restrictions of DAAs for the treatment of Hepatitis C in Canada | CanHepC - Canadian Network on Hepatitis C](https://www.canhepc.ca/sites/default/files/styles/news_full/public/field/image/anitviraux_a_action_directe_9490mv2.jpg?itok=dcj2k1G3)